From LNPs to AAVs: Overcoming RNA Delivery Challenges

RNA therapeutics have great potential, as evidenced by the success of Pfizer-BioNTech and Moderna’s COVID vaccines. One difficulty that may stunt their success lies in their delivery challenges.

Read More


Comments

Leave a Reply

Your email address will not be published. Required fields are marked *